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Identification and Characterization
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of the kinase domain, including Y499 and Y794 (Ste-
phens et al., 1994; Peng et al., 1995). TrkA phosphotyro-
sines and their surrounding amino acid residues serve
as specific recognition sites for effector molecules that
contain either an Src homolog 2 (SH2) domain or a phos-
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photyrosine binding (PTB) domain (domains reviewed by
Pawson and Scott, 1997). Recruitment of Trk effectors
to the plasma membrane initiates signaling events that
Summary promote growth, differentiation, and survival.
Propagation of the TrkA signal within PC12 cells and
Neurotrophins influence growth and survival of spe- neurons is mediated by multiple effectors that influence
cific populations of neurons through activation of Trks, distinct intracellular signaling pathways (Kaplan and
members of the receptor tyrosine kinase (RTK) family. Stephens, 1994; Greene and Kaplan, 1995), including
In this report, we describe the identification and char- Ras-dependent signaling pathways and Ras-indepen-
acterization of two substrates of Trk kinases, rAPS dent signaling pathways. Ras-dependent signaling path-
and SH2-B, which are closely related Src homolog 2 ways mediate NGF induction of MAP kinase (MAPK) (Qiu
(SH2) domain±containing signaling molecules. rAPS and Green, 1992; Thomas et al., 1992; Wood et al., 1992),
and SH2-B are substrates of TrkB and TrkC in cortical morphological differentiation (Hagag et al., 1986; Szeb-
neurons and SH2-B is a substrate of TrkA in sympa- erenyi et al., 1990) and expression of a variety of genes
thetic neurons. Moreover, rAPS and SH2-B bind to in PC12 cells (D'Arcangelo and Halegoua, 1993), and
Grb2, and both are sufficient to mediate NGF induction NGF-dependent survival of small-diameter dorsal root
of Ras, MAP kinase (MAPK), and morphological differ- ganglion (DRG) sensory neurons (Borasio et al., 1989,
entiation of PC12 cells. Lastly, antibody perturbation 1993). Ras-independent signaling pathways mediate
and transient transfection experiments indicate that NGF induction of Na1 channel activity and expression
SH2-B, or a closely related molecule, is necessary for of the type II and PN-1 Na1 channel and Thy-1 genes
NGF-dependent signaling in neonatal sympathetic neu- in PC12 cells (D'Arcangelo and Halegoua, 1993) and
rons. Together, these observations indicate that rAPS survival of sympathetic neurons (Borasio et al., 1993;
and SH2-B mediate Trk signaling in developing neurons. Creedon et al., 1996). Although the identity of TrkA ef-
fectors that influence Ras-dependent and Ras-indepen-
Introduction dent TrkA signaling in neurons remains unclear, two
general tyrosine kinase effector molecules, Shc and
PLC-g, mediate NGF induction of Ras-dependent signal-A variety of extrinsic cues, including soluble neuro-
ing in PC12 cells (Stephens et al., 1994). Shc is an adap-trophic factors, influence differentiation, survival, and
tor protein that couples Trk receptors to Grb2, SOS, andplasticity of developing neurons. One family of neuro-
the Ras±MAPK signaling cascade, and it associates withtrophic factors that contributes to neuronal develop-
TrkA phosphotyrosine residue 499 (pY499) (Obermeierment is the neurotrophins, which includes nerve growth
et al., 1993; Loeb et al., 1994) through its PTB domainfactor (NGF), brain-derived neurotrophic factor (BDNF),
(Kavanaugh and Williams, 1994). PLC-g, an enzyme thatneurotrophin-3 (NT-3), NT-4/5, and NT-6 (reviewed by
catalyzes phosphoinositide turnover and promotes acti-Reichardt and Farinas, 1997). Cell surface receptors for
vation of protein kinase C and the Ras±MAPK signalingneurotrophins are members of the Trk family of receptor
cascade, associates with TrkA phosphotyrosine residuetyrosine kinases (RTKs) (Kaplan et al., 1991a, 1991b;
794 (pY794) through its SH2 domain (Anderson et al.,Klein et al., 1991). TrkA, TrkB, and TrkC are receptors
1990; Obermeier et al., 1993; Loeb et al., 1994). Bothfor NGF, BDNF, and NT-4/5 and NT-3, respectively (re-
Shc and PLC-g are widely expressed in neuronal andviewed by Barbacid, 1995; Bothwell, 1995; Reichardt
nonneuronal cells, and it is likely that they contribute toand Farinas, 1997). In addition, a distinct neurotrophin
Trk signaling in neurotrophin-dependent neurons duringreceptor, p75LNGFR, binds to all neurotrophins (reviewed
neurodevelopment.by Barker, 1998). While the role of p75LNGFR during neuro-
In support of the idea that Shc and PLC-g are essentialdevelopment is not yet fully appreciated, Trk receptors
TrkA effector molecules, the integrity of both TrkA resi-appear to be the major mediators of neurotrophin signal-
dues Y499 and Y794, the binding sites for Shc anding in developing and adult neurons.
PLC-g, respectively, is essential for the NGF inductionUpon binding their ligands, Trk receptors dimerize
of Ras±MAPK signaling and morphological differentia-and autophosphorylate on multiple tyrosine residues in
tion of PC12 cells (Stephens et al., 1994; Inagaki ettrans. Autophosphorylation sites within rat TrkA include
al., 1995). However, considerable evidence supports thetyrosine residues Y679, Y683, and Y684, which are lo-
idea that Shc and PLC-g do not mediate all aspects ofcated within the catalytic loop of the tyrosine kinase
NGF signaling, even in PC12 cells. In addition to rat TrkAdomain, and several tyrosine residues that lie outside
residues Y499 and Y794, the integrity of several other
TrkA tyrosine residues and of a small juxtamembrane
domain of TrkA are essential for TrkA-mediated differen-* To whom correspondence should be addressed (e-mail: david_
ginty@qmail.bs.jhu.edu). tiation of PC12 cells (Inagaki et al., 1995; Peng et al.,
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Figure 1. Identification of Phospho-Trk-Interacting Proteins by a Yeast Two-Hybrid Screen
(A) An overview of two-hybrid screen to identify novel Trk substrates. The baits consisted of the entire intracellular domains of either wild-
type rat TrkA or kinase-deficient TrkAVD mutant that were fused to the DNA binding and dimerization domain of LexA. First, clones that encode
proteins that interacted with phospho-TrkA were identified and isolated. Then, those cDNAs were reintroduced into yeast expressing either
LexA±TrkA or LexA±TrkAVD. Clones that encode proteins that interacted with phospho-TrkA, but not TrkAVD, were characterized further.
(B) LexA±TrkA, but not LexA±TrkAVD, is catalytically active in yeast. Extracts of yeast expressing LexA, LexA±TrkA, or LexA±TrkAVD were
resolved by SDS-PAGE and immunoblotted with either anti-Trk (left) or anti-pY (right).
(C) Deduced amino acid sequence of rAPS. The PH domain and SH2 domain are underlined.
(D) Schematic representation of rAPS and SH2-B proteins. The degree of amino acid identity between several domains of rAPS and SH2-B
are indicated.
(E) rAPS and SH2-B are expressed in E18 cortical neurons grown in vitro as determined by Northern blot.
(F) Shc, PLC-g, rAPS, and SH2-B interact with phospho-TrkA, but not with the TrkAVD mutant. Interactions between PTRIPs and LexA±Trks
were assessed with a liquid b-gal assay using extracts of yeast that were grown in the presence or absence of D-galactose, which controls
expression of interactors.
1995). Moreover, NGF and BDNF induce tyrosine phos- substrates of Trk receptors in developing neurotrophin-
phorylation of many proteins in sympathetic neurons dependent neurons.
and cortical neurons, respectively (for example, see
Senger and Campenot, 1997), and several unidentified
Resultsproteins coprecipitate with TrkA or TrkB from these neu-
rons (unpublished data). Further, TrkA, TrkB, and TrkC
Identification of Proteins that Interact withmediate distinct responses, even within the same cell
Phospho-TrkA, -TrkB, and -TrkCtype (Carter et al., 1995; Iwasaki et al., 1997; McAllister
We employed a yeast two-hybrid screen to identify novelet al., 1997). Since Shc and PLC-g interact with all three
substrates of Trk receptor tyrosine kinases (Figure 1A).Trk receptors, it is likely that each Trk receptor has one
The entire intracellular domains of rat TrkA, TrkB, oror more distinct unidentified substrate(s) that endows it
TrkC were fused to the DNA binding and dimerizationwith a unique signaling capacity. Together, these and
domain of the bacterial transcription factor LexA. Dimer-other observations provide a compelling argument that
ization of the LexA±TrkA fusion protein through the LexAunidentified Trk substrates, which are essential media-
dimerization domain resulted in tyrosine phosphoryla-tors of neurotrophin signaling, must exist. Here, we re-
tion of LexA±TrkA when expressed in yeast (Figure 1Bport the identification and characterization of two struc-
turally related phospho-Trk-interacting proteins that are and data not shown). In addition, a kinase-inactive LexA±
rAPS and SH2-B Are Trk Substrates
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PTRIP-1 and PTRIP-2 Encode rAPS and SH2-B,Table 1. Identification of Phospho-Trk-Interacting
Proteins (PTRIPs) Two Highly Related Adaptor Proteins
One of the cDNA clones encoding PTRIP-1 rescued fromInteraction with Number of
yeast was used as a probe to screen a phage cDNAClones
library prepared from adult rat hippocampus mRNA. The(different
Name LexA±TrkA LexA±TrkAVD fragments) ID largest PTRIP-1 cDNA isolated was 2.9 kb. The coding
sequence of PTRIP-1 starts at nucleotide 272 of thisPTRIP-1 yes no 7 novel
clone; the first methionine codon is located within aPTRIP-2 yes no 5 SH2-B
PTRIP-3 yes no 2 Shc Kozak consensus sequence followed by an open read-
PTRIP-4 yes no 2 PLC-g ing frame (ORF) of 1866 bp. Conceptual translation of
PTRIP-5 to -8 yes no 1 novel the nucleotide sequence of the ORF revealed that it
ID, identity of clone. encodes a novel 621 amino acid protein with a Plecstrin
Number of Clones, number of distinct cDNA fragments isolated. homolog (PH) domain and an SH2 domain. The deduced
amino acid sequence of PTRIP-1 is presented in Figure
1C. PTRIP-1 is likely be the rat ortholog of human APS
TrkAVD variant was generated by altering the coding de- (Yokouchi et al., 1997) because the two proteins are
terminants of a valine at position 527 (Val-527) of TrkA overall 82% identical, and therefore we have used the
to an aspartic acid. TrkA Val-527 resides within the in- name rAPS to describe this protein. We also isolated a
variant glycine loop of all protein kinases and is highly full-length cDNA clone encoding PTRIP-2. Sequence
conserved among protein tyrosine kinases (Hanks et al., analysis of this clone revealed that PTRIP-2 is identical
1988). Mutation of the analogous valine residue of erbB to SH2-B, a previously identified rat protein that can
to an aspartic acid completely abolished its catalytic bind to the g subunit of the high-affinity IgE receptor,
activity (Shu et al., 1994). The LexA±TrkAVD mutant was FceRI (Osborne et al., 1995). Interestingly, rAPS and
expressed in yeast, but it was not catalytically active SH2-B are overall 37% identical and 60% similar to each
(Figure 1B). Expression of LexA±TrkA, LexA±TrkB, LexA± other. The N-terminal proline-rich domains, the PH do-
TrkC, or LexA±TrkAVD did not substantially affect the mains, the SH2 domains, and the C-terminal tyrosine-
growth of yeast (data not shown), even though several containing motifs are all highly conserved between rAPS
endogenous yeast proteins were phosphorylated by the and SH2-B, as is the general organization of these do-
catalytically active LexA±Trk proteins (Figure 1B). mains (Figure 1D). Besides three conserved tyrosine
To identify proteins that associate with autophosphor- residues within the PH domains and SH2 domains, two
ylated TrkA, we employed LexA±TrkA as a bait and a other tyrosine residues are conserved in both proteins;
yeast cDNA expression library prepared from mRNA one in the context of an N/HPXY motif (Y55 in SH2-B)
isolated from rat embryonic day 14 (E14) spinal cord and the other in an YXXL motif (Y753 in SH2-B). These
and DRG. mRNA from E14 spinal cord and DRG was tyrosine-containing motifs may be recognition sites for
used as a template for cDNA synthesis because all three other signaling proteins that contain PTB or SH2 do-
Trks are expressed in one or more subsets of neurons mains, respectively.
within this tissue, and mice lacking either TrkA, TrkB,
or TrkC exhibit severe neuropathies of specific classes
of DRG neurons (reviewed by Reichardt and Farinas, NGF Promotes an Association between
rAPS and SH2-B and TrkA1997). Thus, natural substrates of all three Trk receptors
are expressed in embryonic spinal cord and DRG. A Effectors of RTKs bind directly to specific phosphoty-
rosine residues, and insight into their function can betotal of 19 cDNAs were identified that encode proteins
that conferred Leu-independent growth of LexA±TrkA obtained from structure±function studies that identify
specific domains that mediate the association betweenbut not LexA±TrkAVD yeast. Sequence analysis revealed
that these cDNAs encode eight distinct proteins. We RTKs and their effectors. Thus, we sought to identify
TrkA tyrosine residues critical for the interaction be-have named the TrkA-interacting clones PTRIPs (phos-
phoTrk interacting proteins). Distinct fragments of cDNAs tween TrkA and rAPS and SH2-B. Since rAPS and SH2-B
contain SH2 domains, and since they interact with phos-encoding PTRIP-1 and PTRIP-2 were identified most
often, two distinct cDNAs encoding either PTRIP-3 or pho-Trks, but not unphosphorylated Trks, it is likely that
the SH2 domains mediate their association with TrkA.-4 and one cDNA fragment encoding PTRIP-5±PTRIP-8
were obtained (Table 1). Sequence analysis revealed In support of this idea, one clone isolated in our screen
encodes only the SH2 domain and the short C terminusthat PTRIP-3 encodes Shc and PTRIP-4 encodes PLC-g,
both of which are previously identified substrates of of SH2-B (data not shown). To identify tyrosine residues
of TrkA that mediate its association with the rAPS andTrkA (see Introduction). Like Shc and PLC-g, PTRIP-1
and PTRIP-2 interacted strongly with LexA±TrkA, LexA± SH2-B SH2 domains, we performed yeast two-hybrid ex-
periments employing a series of TrkA mutants in whichTrkB, and LexA±TrkC in yeast (Figure 1F and data not
shown). Since multiple distinct cDNAs encoding PTRIP-1 individual or multiple tyrosine residues were changed
to phenylalanine (Figure 2A and data not shown; Inagakiand PTRIP-2 were obtained most often in our screen
(Table 1), and since these PTRIPs are expressed in de- et al., 1995). Interestingly, rAPS and SH2-B interacted
with the LexA±TrkA mutant F8 in which all conservedveloping brain, spinal cord, and primary embryonic corti-
cal neurons (Figure 1E and data not shown), we have tyrosine residues within the intracellular TrkA domain
are mutated to phenylalanine, except Y679, Y683, andfocused our attention on PTRIP-1 and PTRIP-2 as medi-
ators of Trk signaling in developing neurons. Y684 within the catalytic loop (Figure 2B). In contrast,
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from extracts of NGF-treated 293 cells but not untreated
cells. In addition, NGF induced tyrosine phosphorylation
of rAPS and SH2-B (Figure 2C). Similar results were
obtained from 293 cells that coexpressed either rAPS
or SH2-B with TrkB or TrkC and were treated with BDNF
or NT-3, respectively (data not shown). Lastly, NGF trig-
gered an association between the TrkA mutant F8 and
myc±rAPS and myc±SH2-B as well as F8-mediated tyro-
sine phosphorylation of both of these PTRIPs (Figure
2C). Taken together, these results indicate that neuro-
trophins can induce an association between rAPS and
SH2-B and membrane-bound Trk receptors.
NGF, BDNF, and NT-3 Induce Tyrosine
Phosphorylation of rAPS and SH2-B
in Neurons
To determine whether rAPS and SH2-B are natural Trk
substrates in neurons, immunoprecipitation and immu-
noblot experiments were performed using extracts of
neurotrophin-treated cortical neurons or sympathetic
neurons. For these experiments, rabbit polyclonal anti-
bodies directed against rAPS and SH2-B fusion proteins
were generated. Anti-rAPS and anti-SH2-B, but not pre-
immune sera, recognized their respective recombinant
proteins (Figures 3A and 3B), and they did not cross-
react (data not shown).
SH2-B and rAPS are substrates of Trk receptors in
embryonic cortical neurons. Anti-SH2-B antibodies, but
not preimmune sera, detected multiple proteins in theFigure 2. rAPS and SH2-B Interact with TrkA and F8 in Yeast and
range of 90±110 kDa from extracts of cortical neurons293 Cells
by immunoblot analysis. Upon exposure of cortical neu-(A) Schematic diagram of the intracellular domains of TrkA and TrkA
rons to BDNF for 5 min, there was a marked mobilitymutant F8 (rat sequence).
(B) Interactions between Shc, PLC-g, rAPS, or SH2-B and wild- shift of these proteins, most likely due to their tyrosine
type TrkA or the F8 mutant in yeast. The degree of interaction was phosphorylation (Figure 3A). An identical pattern was
assessed by a yeast two-hybrid liquid b-gal assay. The b-gal activity detected in immunoblot experiments using a different
is shown in relative units.
SH2-B antibody (data not shown). One of the major pro-(C) rAPS and SH2-B associate with TrkA and the TrkA mutant F8 in
teins detected by anti-SH2-B by immunoblot analysisan NGF-dependent manner in HEK 293 cells. Either myc-tagged
of extracts of cortical neurons comigrated with SH2-BrAPS or SH2-B was expressed in 293 cells in the presence or ab-
sence of either TrkA or F8. Cell extracts were subjected to immuno- detected in extracts of 293 cells transfected with an
precipitation using anti-myc monoclonal antibodies. The immune SH2-B expression vector (Figure 3A). These results dem-
complexes were resolved by SDS-PAGE and immunoblotted with onstrate that the SH2-B antibodies are specific and they
anti-Trk, anti-pY, anti-myc, and anti-Grb2 antibodies.
are consistent with the idea that SH2-B is rapidly post-
translationally modified following Trk receptor activa-
tion. To directly establish whether rAPS and SH2-B areShc and PLC-g interacted with TrkA mutants only when
Y499 or Y794 are intact. For example, Shc and PLC-g phosphorylated on tyrosine residues following Trk re-
ceptor activation, rAPS and SH2-B antibodies were useddid not interact with F8 (Figure 2B). Therefore, rAPS and
SH2-B, Shc, and PLC-g can associate with TrkA through to immunoprecipitate rAPS and SH2-B from extracts of
cortical neurons, immune complexes were resolved bydistinct domains of TrkA. While the interactions between
Shc and PLC-g and TrkA require TrkA phosphotyrosine SDS-PAGE, and immunoblot analyses were done with
anti-phosphotyrosine. BDNF effectively induced tyro-residues Y499 or Y794, rAPS and SH2-B can interact with
catalytically active TrkA through association of other sine phosphorylation of a protein recognized by the
rAPS antisera but not preimmune antisera (Figure 3B).domains, possibly through direct binding to TrkA phos-
photyrosine residues Y679, Y683, and/or Y684 TrkA within Identical results were obtained in experiments employ-
ing a goat antibody raised against a distinct domain ofthe catalytic loop domain. Alternatively, rAPS and SH2-B
may bind to a distinct TrkA domain that is made available human APS (data not shown). Moreover, rAPS is tyrosine
phosphorylated upon exposure of cortical neurons tofor binding following autophosphorylation of the cata-
lytic loop tyrosines. either BDNF or NT-3 (Figure 3B), and BDNF induction
of phosphorylation of rAPS occurs within 1 min andIf rAPS and SH2-B are substrates of TrkA, then they
should associate with TrkA upon exposure of cells to persists for more than 60 min (Figure 3C). Likewise,
BDNF induction of tyrosine phosphorylation of SH2-BNGF. To address this possibility, we coexpressed either
myc-tagged rAPS (myc±rAPS) or myc±SH2-B with either peaked within 2 min of exposure of cortical neurons to
BDNF and persisted for at least 1 hr (Figure 3C). Infull-length TrkA or the TrkA mutant F8 in HEK 293 cells.
TrkA coprecipitated with both myc±rAPS and myc±SH2-B contrast to these results with cortical neurons, we failed
rAPS and SH2-B Are Trk Substrates
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Figure 3. Neurotrophins Induce Tyrosine Phosphorylation of rAPS and SH2-B in Cortical and Sympathetic Neurons
(A) BDNF or NGF induce a mobility shift of SH2-B in cortical neurons or HEK 293 cells, respectively. 293 cells expressing recombinant SH2-
B and TrkA were stimulated with vehicle or NGF (100 ng/ml, 10 min). Cell extracts were analyzed by immunoblotting with anti-SH2-B antisera
(right). Alternatively, extracts of cultured embryonic cortical neurons stimulated with vehicle control or BDNF (50 ng/ml, 10 min) were prepared
and analyzed by immunoblotting with either preimmune sera (PI) or anti-SH2-B antisera (I) (left). Anti-SH2-B did not recognize any protein in
extracts of mock-transfected 293 cells (data not shown).
(B) rAPS is a substrate of both TrkB and TrkC in cortical neurons. Rat E18 cortical cultures were stimulated with BDNF or NT3 (100 ng/ml,
10 min) (left), and 293 cells expressing rAPS and TrkA were stimulated with NGF (right). Cell extracts were immunoprecipitated with anti-rAPS
antibodies and immune complexes analyzed by immunoblot with anti-pY.
(C) Time course of BDNF induction of tyrosine phosphorylation of rAPS and SH2-B in cortical neurons. Cortical neurons were treated with
BDNF for indicated times, cell extracts prepared and subjected to immunoprecipitation with either anti-rAPS or anti-SH2-B, and immune
complexes analyzed by immunoblot with anti-pY.
(D) Grb2 coprecipitates with rAPS from extracts of cortical neurons. Cortical neurons were untreated or treated with BDNF, and extracts were
prepared and subjected to immunoprecipitation with anti-rAPS. Immune complexes were subjected to immunoblot using either anti-Grb2,
anti-pY, or anti-APS.
(E) SH2-B is a substrate of TrkA in sympathetic neurons. Rat neonatal sympathetic neurons were grown in low NGF (2 ng/ml) medium for 48
hr and then exposed to a high concentration of NGF (200 ng/ml, 10 min). Immunoprecipitation with anti-SH2-B or preimmune antisera
and immunoblot with anti-pY were performed as above. Abbreviations: PI, preimmune sera; I, immune sera; CE, cell extracts; and IP,
immunoprecipitation.
to detect tyrosine-phosphorylated rAPS or SH2-B in ex- NGF (Figure 3E). Importantly, this protein comigrates
with one of the major tyrosine phosphorylated proteinstracts prepared from NGF-treated PC12 cells (data not
shown). in extracts of NGF-treated sympathetic neurons (Figure
3E). Taken together, these results indicate that rAPSSince neonatal sympathetic neurons require NGF for
growth and survival, we next sought to determine and SH2-B are substrates of TrkB and TrkC in embryonic
cortical neurons, and SH2-B is a substrate of TrkA inwhether either rAPS or SH2-B is a substrate of TrkA in
sympathetic neurons. RT-PCR experiments demonstrated neonatal sympathetic neurons.
that SH2-B is expressed in these neurons (data not
shown). Anti-SH2-B precipitated a protein from NGF- rAPS and SH2-B Are Mediators of NGF Signaling
to the Ras±MAPK Pathwaytreated sympathetic neurons that comigrated with re-
combinant SH2-B and that was phosphorylated on tyro- Since rAPS and SH2-B have conserved structural do-
mains and tyrosine residues that are likely to mediatesine residues following exposure of these neurons to
Neuron
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Figure 4. rAPS and SH2-B Mediate NGF In-
duction of MAPK and Neuritogenesis
(A) rAPS and SH2-B mediate TrkA and F8
activation of MAPK. 293 cells transfected
with expression vectors encoding rAPS or
SH2-B and either TrkA or F8 and HA-tagged
ERK1 were stimulated with NGF (100 ng/ml,
10 min). HA-ERK1 was immunoprecipitated
from cell extracts with an anti-HA antibody,
and its activity was measured by an immune
complex kinase assay. The immune com-
plexes were then immunoblotted with anti-
HA antibody (bottom). Similar results were
obtained in three experiments performed in
duplicate.
(B) RasN17 inhibits the rAPS and SH2-B-
mediated MAPK activation. rAPS or SH2-B
were transiently expressed with F8 and ERK1
in the absence or presence of an expression
vector encoding RasN17 in 293 cells. Cells
were treated and MAPK activity was mea-
sured as above. Similar results were obtained
in three experiments performed in duplicate.
(C) rAPS and SH2-B can mediate NGF induc-
tion of morphological differentiation of PC12
cells. Wild-type TrkA or the TrkA mutant F8
in the presence or absence of either rAPS or
SH2-B was transiently expressed in PC12nnr5
cells along with GFP. Cells were incubated
with NGF (100 ng/ml) for 3 days after transfec-
tion. Then, cells were fixed and transfected
cells were identified by fluorescence micros-
copy.
(D) Quantitation of neurite outgrowth was per-
formed as described in the Experimental Pro-
cedures. The results are means 6 SEM of
three experiments performed in duplicate.
protein±protein interactions, we investigated whether cells that expressed F8 and either rAPS or SH2-B (Figure
4B). Together, these experiments demonstrate thatrAPS and/or SH2-B interact with other known signaling
molecules. We found that Grb2, an adaptor protein that rAPS and SH2-B can mediate NGF/TrkA activation of
the Ras-dependent MAPK signaling cascade.contains one SH2 domain flanked by two SH3 domains
(Lowenstein et al., 1993), associates with both myc±
rAPS and myc±SH2-B expressed in 293 cells (Figure rAPS and SH2-B Mediate NGF Induction of Neurite
Outgrowth in PC12nnr5 Cells2C) as well as endogenous rAPS expressed in cortical
neurons (Figure 3D). The possibility that rAPS and SH2-B To determine whether rAPS and SH2-B are sufficient to
mediate NGF induction of morphological differentiation,can couple Trk receptors to the Ras-dependent signal-
ing pathway was tested next. rAPS or SH2-B were coex- we performed experiments employing PC12nnr5 cells,
which express little or no TrkA and are unresponsive topressed with HA-tagged ERK1 and either TrkA or F8 in
293 cells, and then the ability of NGF to induce MAPK NGF (Green et al., 1986). As shown previously (Loeb et
al., 1991), expression of exogenous TrkA in PC12nnr5activity in transfected cells was determined by an im-
mune complex kinase assay. As expected, NGF did not cells restored NGF sensitivity (Figures 4C and 4D). Be-
cause rAPS and SH2-B can associate with F8 (Figureinduce the activity of MAPK in cells that were not trans-
fected with the TrkA expression vector. However, NGF 2), and because the TrkA mutant F8 cannot mediate NGF
induction of morphological differentiation of PC12nnr5did evoke robust activation of MAPK in 293 cells that
coexpressed TrkA and HA-ERK, and coexpression of cells (Figures 4C and 4D and Inagaki et al., 1995), we
determined whether rAPS and SH2-B can mediate NGFTrkA with either rAPS or SH2-B enhanced NGF induction
of MAPK activity (Figure 4A). In contrast, the TrkA mu- induction of morphological differentiation of these cells
when coexpressed with F8. NGF did not promote mor-tant, F8, did not mediate NGF induction of MAPK activity
in the absence of rAPS and SH2-B. However, coexpres- phological differentiation of PC12nnr5 cells that ex-
pressed rAPS, SH2-B, or F8 alone (Figures 4C and 4Dsion of either rAPS or SH2-B with F8 conferred NGF
induction of MAPK (Figure 4A). In addition, NGF induc- and data not shown). In contrast, NGF elicited robust
outgrowth of neurites in cells that coexpressed F8 withtion of MAPK was dependent on Ras; the dominant-
inhibitory Ras mutant, RasN17 (Feig and Cooper, 1988), either rAPS or SH2-B (Figures 4C and 4D). Consistent
with the finding that rAPS and SH2-B can mediate NGFcompletely blocked NGF induction of MAPK activity in
rAPS and SH2-B Are Trk Substrates
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Figure 5. SH2-B Constitutively Binds to Grb2 through a Proline-Rich Domain that Contributes to SH2-B Signal Transduction
(A) Schematic diagrams of SH2-B deletion and tyrosine mutants. The proline-rich motifs are underlined in wild-type SH2-B.
(B) Grb2 associates with SH2-B via the proline-rich motif located between the PH and SH2 domains. Myc-tagged SH2-B mutation and deletion
constructs were expressed in 293 cells. Cell extracts were then subjected to immunoprecipitation using anti-myc antibody. Immune complexes
were immunoblotted with anti-Grb2 (upper) and anti-myc antibodies (bottom).
(C) The internal deletion mutant (M7) was coexpressed with TrkA in 293 cells, and cells were stimulated with NGF (100 ng/ml, 10 min). Cell
extracts were subjected to immunoprecipitation using anti-myc antibody. Immune complexes were immunoblotted with anti-Grb2 (upper),
anti-pY (middle), and anti-myc (bottom) antibodies.
(D) The N terminus and a proline-rich domain of SH2-B contribute to NGF induction of SH2-B-mediated MAPK activation. NGF induction of
MAPK mediated by vector, SH2-B, M7, M5, or SH2-B 1 M5 was assessed in 293 cells. DNA amounts used for transfections were: HA-ERK1,
5 mg; F8, 2 mg; WT SH2-B, 2 mg; M7, 2 mg; M5, 2 mg; and WT SH2-B 1 M5, 2 mg1 10 mg, respectively (total amount of DNAs including empty
vector was 17 mg). Each experiment was performed three times in duplicate or triplicate.
(E) M5 does not block NGF induction of MAPK mediated by wild-type TrkA in 293 cells. Cells were transfected with expression vectors
encoding TrkA (5 mg) and either empty vector or M5 (5 mg) and HA-ERK1 (5 mg), and MAPK immune complex kinase assays and immunoblotting
were done as above.
activation of Ras-dependent signaling (Figures 4A and of SH2-B that mediate its association with Grb2, we
expressed a series of altered myc±SH2-B proteins (Fig-4B), these results indicate that rAPS and SH2-B have
the capacity to mediate TrkA induction of morphological ure 5A) in 293 cells and performed immunoprecipitation
and immunoblotting experiments. An SH2-B mutantdifferentiation in PC12 cells.
lacking the conserved tyrosine residues Y55 and Y751
(mutant M1) bound normally to Grb2 (Figure 5B), demon-SH2-B Mediates Grb2-Dependent
and Grb2-Independent strating that the SH2-B±Grb2 association is not depen-
dent upon phosphorylation of these SH2-B residues. InTrkA Signaling
While the interaction between rAPS and Grb2 is partially addition, deletion of the conserved N-terminal proline-
rich domain (amino acids 1±28) (M3), both the N-terminaldependent on tyrosine phosphorylation of rAPS, un-
phosphorylated SH2-B can bind constitutively to Grb2 and the C-terminal proline-rich domains (M6), and the
PH domain of SH2-B did not affect its association with(Figure 2C). This observation suggests that Grb2 binds
SH2-B through its SH3 domain. To identify domains Grb2. However, an SH2-B deletion mutant lacking the
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N-terminal half of SH2-B (M5), which contains the N-ter-
minal proline-rich domain, the PH domain, and a proline-
rich motif located between the PH and SH2 domains, did
not interact with Grb2 (Figure 5B). Moreover, a mutant
lacking only the proline-rich region located between the
PH and SH2 domains did not bind to Grb2 (Figure 5C).
Together, these results indicate that SH2-B associates
directly and constitutively with Grb2, and that the pro-
line-rich motif located between the PH and SH2 domains
of SH2-B is responsible for this association. To test
whether the association between SH2-B and Grb2 is
essential for Trk-activated SH2-B-mediated signal trans-
duction events, we employed the SH2-B mutants M5
and M7 in MAPK activation experiments. Upon exposure
of cells to NGF, mutant M7 associates with TrkA and
becomes phosphorylated on tyrosine residues, but it Figure 6. SH2-B Is Necessary for NGF-Dependent, but Not cAMP-
Dependent, Survival of Sympathetic Neuronscan no longer bind to Grb2 (Figure 5C). M7 and, to a
greater extent, M5 were compromised in their ability to Anti-SH2-B (I) but not preimmune (PI) antibodies kill dissociated
sympathetic neurons grown in the presence of NGF but not in themediate NGF induction of MAPK (Figure 5D). Moreover,
presence of forskolin. Dissociated sympathetic neurons were in-M5 effectively blocked NGF induction of F8/SH2-B-medi-
jected with either anti-SH2-B antibodies or preimmune IgG by theated MAPK activity (Figure 5D). In contrast, M5 did not
trituration method. Subsequently, cells were plated, grown in the
block the ability of wild-type TrkA to mediate NGF induc- presence of either NGF (200 ng/ml) or forskolin (FSK) (10 mM), and
tion of MAPK (Figure 5E). These observations demon- fixed at the indicated times. Fixed cells were stained for MAP-2
strate that SH2-B mediates NGF induction of MAPK, in immunoreactivity and MAP-2-immunoreactive cells counted. Each
data point represents the average 6 SEM of three experiments,part, through its constitutive association with the pre-
each performed with three cultures. Asterisk indicates statisticalviously characterized signaling molecule Grb2. More-
difference from preimmune-treated neurons (p , 0.05).over, these results demonstrate that the SH2-B mutant
M5 specifically blocks SH2-B-mediated signaling to
MAPK; it does not block SH2-B-independent TrkA sig-
35% and 43% fewer neurons were found in anti-SH2-naling to the Ras/MAPK pathway.
B-triturated cultures 60 and 84 hr after plating, respec-
tively. In contrast, neither SH2-B antibodies nor preim-
mune IgG affected survival of sympathetic neuronsSH2-B Is Necessary for NGF Signaling in Primary
Sympathetic Neurons grown in the presence of forskolin (Figure 6). Similar
results were obtained when cells were stained with acri-Since SH2-B is a TrkA substrate in sympathetic neurons
(Figure 3E), and since neonatal sympathetic neurons dine orange and MAP-2 to identify viable neurons (data
not shown). Together, these data indicate that SH2-Brequire NGF and TrkA for growth and survival, we sought
to determine whether the TrkA±SH2-B interaction was is required for NGF/TrkA-dependent, but not cAMP-
dependent, survival of neonatal sympathetic neurons.necessary for TrkA signaling in these neurons. Two com-
plementary approaches were taken. First, anti-SH2-B As a second approach to establish a role for TrkA±
SH2-B signaling in NGF/TrkA-dependent growth of sym-antibodies, described above, were introduced into dis-
sociated sympathetic neurons by the trituration method pathetic neurons, we performed experiments in which
an SH2-B mutant that blocks SH2-B signaling was intro-(see Experimental Procedures), and then survival of neu-
rons was determined over the course of several days. duced into neurons within explants of sympathetic gan-
glia. As shown in Figures 5D and 5E, the SH2-B mutantTwo control experiments were performed in parallel to
establish specificity of this approach. First, the effects M5 is incapable of mediating TrkA signaling to MAPK,
and it blocks SH2-B-dependent, but not SH2-B-inde-of preimmune IgG trituration on survival of sympathetic
neurons were assessed. Second, the effects of anti- pendent, signaling to MAPK when expressed in 293
cells. Therefore, M5 is a dominant-interfering SH2-BSH2-B and preimmune antibodies on growth and sur-
vival of sympathetic neurons grown in the presence of mutant useful for blocking SH2-B-mediated signaling
events. Expression vectors encoding either wild-typeforskolin were determined. Because NGF/TrkA signal-
ing is not required for survival of sympathetic neurons SH2-B or mutant M5 were introduced into sympathetic
neurons within explants of neonatal superior cervicalgrown in the presence of forskolin and other agents that
increase intracellular levels of cyclic AMP (cAMP) (Rydel ganglia (SCG) together with an expression vector encod-
ing green fluorescent protein (GFP) by particle-mediatedand Greene, 1988), inhibition of TrkA effectors should
not affect cAMP-dependent growth and survival of these gene transfer. Up to 200 transfected neurons within the
explants were readily detected by fluorescence micros-neurons.
Neonatal sympathetic neurons triturated with anti- copy (Figure 7A), which represents fewer than 5% of
the total neurons within the explants. Neurons trans-SH2-B antibodies, but not preimmune IgG, exhibited a
reduced rate of survival when grown in NGF-containing fected with an expression vector encoding wild-type
SH2-B thrived and had elaborate, long-branching axonalmedia (Figure 6). Thirty-six hours after plating, 32%
fewer MAP-2-positive neurons were identified in cul- processes that extended up to 2 mm in length when
grown in the presence of either NGF or forskolin for thetures derived from cells triturated with anti-SH2-B com-
pared to cells triturated with preimmune IgG. Likewise, duration of the experiment (Figures 7B and 7C), which
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Figure 7. A Dominant-Interfering Mutant of SH2-B Promotes Degeneration of Axons of Sympathetic Neurons in Explants of SCG Grown in
the Presence of NGF but Not Forskolin
SCG explants were grown for 16 hr in growth medium containing NGF (200 ng/ml). Then, expression vectors encoding GFP and either wild-
type SH2-B or SH2-B mutant M5 were introduced into neurons by particle-mediated gene transfer. Subsequently, medium was replaced with
growth medium containing either NGF (200 ng/ml) or forskolin (10 mM).
(A) Photograph of an SCG explant transfected with wild-type SH2-B and grown in medium containing NGF for 2 days. The photograph was
taken under fluorescence microscopy to identify GFP-positive axons.
(B) The number of fluorescent axons identified from ganglia transfected with either wild-type SH2-B (WT) or SH2-B mutant M5 and grown in
the presence of either NGF or forskolin (FSK). The data represent means 6 SEM of fluorescent axons identified in 15 transfected ganglia.
Statistical analysis indicated that there were fewer GFP-positive neurons in explants transfected with M5 and grown in the presence of NGF
as compared to the other three groups at 48 and 72 hr (p , 0.001).
(C) Representative axons from neurons that were transfected with either wild-type SH2-B (a and c) or SH2-B mutant M5 (b and d) and grown
in medium containing either NGF (200 ng/ml [a and b]) or forskolin (10 mM [c and d]) for 2 days following particle-mediated gene transfer.
Scale bar, 100 mm (A); 25 mm (C).
was for 3 days following the transfection. These axonal neurons expressing M5 survived and maintained long,
healthy axonal processes, often with large growth cones,processes were not obviously different from processes
of neurons transfected with GFP alone. In dramatic con- when grown in the presence of forskolin (Figure 7C).
Therefore, M5 was not generally toxic to sympathetictrast, expression of M5 resulted in a near complete elimi-
nation of axonal processes of neurons grown in the neurons; it was only toxic for neurons grown in the pres-
ence of NGF. Quantitation of the total number of GFP-presence of NGF. After 2 days, many of the axons of
M5-expressing neurons had a broken, granulated ap- positive axons emanating from explants transfected
with expression vectors encoding either wild-typepearance (Figure 7C). This degeneration-promoting ef-
fect of M5 was only seen in transfected neurons; axons SH2-B or mutant M5, and grown in the presence of
either NGF or forskolin, is presented in Figure 7B. Theof untransfected neurons were normal in appearance, as
determined by phase contrast microscopy or following total number of GFP-positive axons was greatly reduced
in M5-transfected neurons grown in the presence ofimmunostaining with anti-neurofilament antibodies (Fig-
ure 7C, insets). Importantly, while dramatic axonal de- NGF, but not forskolin (p , 0.001), measured 2 or 3
days following transfection. Together with the resultsgeneration resulted following expression of M5 in sym-
pathetic neurons maintained in the presence of NGF, of antibody perturbation experiments described above,
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these results indicate that SH2-B, rAPS, or a closely some aspects of neurotrophin signal transduction. Ei-
ther of these Trk substrates can mediate Trk signalingrelated molecule is a critical mediator of NGF/TrkA sig-
nals, but not cAMP signals, that support axon growth to MAPK and morphological differentiation when ex-
pressed in 293 cells or PC12 cells. Evidence in supportof sympathetic neurons.
of a role for SH2-B in TrkA signaling in sympathetic
neurons comes from two different sets of experiments.
Discussion First, injection of anti-SH2-B antibodies, but not preim-
mune antibodies, by trituration led to death of sympa-
Neurotrophins influence growth, differentiation, and sur- thetic neurons that were grown in the presence of NGF.
vival of neurons through activation of their cell surface However, cAMP-mediated survival of sympathetic neu-
receptors, members of the Trk family of RTKs. In this rons was unaffected by the introduction of anti-SH2-B
study, we describe the identification and characteriza- antibodies. Therefore, anti-SH2-B antibodies were not
tion of two substrates of Trk receptors, rAPS and SH2-B. simply toxic to the cells; rather, the anti-SH2-B antibod-
rAPS and SH2-B interact with TrkA, TrkB, and TrkC, ies killed the sympathetic neurons in a TrkA-dependent
suggesting that they are general substrates of Trk recep- manner. Similarly, expression of the dominant interfering
tors. Moreover, these proteins are endogenous sub- SH2-B mutant M5 led to axonal degeneration of sympa-
strates of Trk receptors in developing cortical neurons, thetic neurons grown in the presence of NGF but not
and, importantly, SH2-B is a substrate of TrkA in neona- in the presence of forskolin. Thus, like anti-SH2-B, M5
tal sympathetic neurons. rAPS and SH2-B are found selectively led to degeneration of axons under condi-
complexed with Grb2, and these adaptor proteins are tions that require TrkA signaling. Moreover, experiments
sufficient to mediate NGF/TrkA induction of Ras-depen- presented in Figure 5 demonstrate that while M5 effec-
dent signaling and morphological differentiation, in part, tively blocked SH2-B-mediated signaling events, it did
through their association with Grb2. Lastly, SH2-B is not block SH2-B-independent TrkA signaling. Therefore,
necessary for NGF-dependent signaling in neonatal sym- M5 appears to function as a specific and effective inhibi-
pathetic neurons in vitro. Together, these observations tor of TrkA signaling. How M5 blocks SH2-B signaling
provide evidence for critical roles of rAPS and SH2-B is unclear. In addition to its ability to associate with
in Trk receptor signaling in developing neurons. Grb2, our preliminary studies have indicated that SH2-B
forms homodimers as well as heterodimers with rAPS;
M5 is incapable of forming homo- and heterodimersLnks, a Family of Tyrosine Kinase
(X. Q. and D. D. G., unpublished data), and it cannotSignaling Molecules
associate with Grb2 (Figure 5). Therefore, it is possiblerAPS and SH2-B are highly related proteins with very
that M5 blocks SH2-B function because it interacts withsimilar domain structures. Both contain a PH domain,
the SH2-B binding site on TrkA, but it cannot form dimersan SH2 domain, a C-terminal tyrosine-containing motif,
or bind to downstream signaling molecules, such asand several proline-rich motifs. rAPS is likely to be the
Grb2, that may be necessary for its signaling function.rat ortholog of a recently identified human protein, APS,
Regardless of the mechanism of action of M5, resultswhich interacts with c-kit RTK (Yokouchi et al., 1997);
of these inhibition experiments indicate that SH2-B orSH2-B was first identified as a protein that binds to the
a closely related molecule is necessary for TrkA signalhigh-affinity IgE receptor, FceRI (Osborne et al., 1995).
transduction events that support growth of sympatheticIn addition, two splice variants of SH2-B, SH2-Bb (Rui
neurons.et al., 1997) and PSM (Riedel et al., 1997), were recently
identified. Lastly, parts of the PH domains, the SH2 do-
Mechanism of rAPS and SH2-B Actionmains, and the C-terminal regions of rAPS, APS, and
rAPS and SH2-B have no readily identifiable catalyticSH2-B/SH2-B are similar to a previously described pro-
activity, and it is likely that they function solely as adap-tein, Lnk, which associates with the T cell receptor com-
tor proteins. We have shown that the signaling moleculeplex (Huang et al., 1992). Thus, rAPS/APS, SH2-B/SH2-
Grb2 associates with both rAPS and SH2-B, and struc-Bb/PSM, and Lnk are members of a growing family of
ture±function experiments suggest that the associationstructurally related signaling molecules. Interestingly,
between SH2-B and Grb2 is at least partly responsiblemembers of this family have the capacity to directly
for its mediation of Ras-dependent MAPK (Figure 5)interact with RTKs (this study and Riedel et al., 1997;
and morphological differentiation of PC12 cells (dataYokouchi et al., 1997), the nonreceptor tyrosine kinase
not shown). Our preliminary studies suggest that Y55,JAK2 (Rui et al., 1997), and substrates of tyrosine ki-
Y753, and at least one additional tyrosine residue ofnases (Osborne et al., 1995) through their highly con-
SH2-B are phosphorylated by TrkA (data not shown).served SH2 domains. These observations, together with
Y55 lies within the context of a putative PTB bindingthe widespread expression patterns of members of this
site, an N/HPXY motif, and this residue is not essentialgene family (data not shown and Osborne et al., 1995;
for the association between SH2-B and Grb2. Rather,Yokouchi et al., 1997), suggest that its members function
this tyrosine residue and the C-terminal residue Y753as general mediators of phosphotyrosine signaling cas-
may contribute to the binding sites for other unidentifiedcades in neuronal and nonneuronal cells.
signaling molecules. Indeed, when the analogous tyro-
sine residue in Lnk, Y297, is phosphorylated, it mediates
Function of rAPS and SH2-B during Trk Signaling an interaction between Lnk and PI-3 kinase in lympho-
The present study provides evidence that SH2-B and cytes (Huang et al., 1992). However, we have been un-
successful in detecting an interaction between eitherrAPS are sufficient, and SH2-B is necessary for at least
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plated on collagen-coated 60 mm dishes at a density of 1 3 106rAPS or SH2-B and the regulatory subunit of PI-3 kinase
cells per plate and grown in growth medium (DMEM containing 10%in extracts of either transiently transfected 293 cells or
fetal bovine serum, 5 mM arabinosylcytosine [Ara-C], and NGF [200extracts of cortical neurons. The identity of proteins
ng/ml]). Medium was replaced every 3 days. After 8±10 days, neu-
that may associate with either SH2-B and/or rAPS and rons were starved in medium containing a low concentration of NGF
mediate aspects of neurotrophin signaling in developing (2 ng/ml) for 48 hr prior to stimulation with NGF (200 ng/ml, 10 min).
neurons remains unknown.
Yeast Two-Hybrid Screening and cDNA CloningSurprisingly, rAPS and SH2-B were found to associate
of rAPS and SH2-Bwith TrkA variants lacking all tyrosines except the three
To identify novel substrates of Trk family RTKs, a yeast two-hybridphosphotyrosine residues within the catalytic loop of
screen was used (Gyuris et al., 1993). Briefly, the entire intracel-the TrkA kinase domain. The TrkA mutant F8, which has
lular domains of TrkA, TrkB, or TrkC were inserted into the yeast
all tyrosine residues changed to phenylalanine except expression vector PEG202 as a fusion to the LexA DNA binding and
Y679, 683, and 684 within the catalytic loop, interacts dimerization domain and introduced into the yeast strain PJK103.
with both rAPS and SH2-B in yeast and in mammalian In addition, a mutant LexA±TrkV527D was generated by PCR-mediated
site-directed mutagenesis. A cDNA library generated from mRNAcells (Figure 2). However, the possibility that rAPS and
isolated from rat E14 spinal cord and DRG (Kolodkin et al., 1997)SH2-B can associate with tyrosine residues outside of
was cloned into the yeast expression vector pJG4/5, which confersthe catalytic loop was not ruled out in the present study
expression of the cDNA fused with a strong transcription activator
because TrkA mutants lacking tyrosine residues within (Golemis et al., 1994). A screen of 30 million transformants was
the catalytic loop are deficient in kinase activity and, performed. Interaction with LexA±TrkA and/or LexA±TrkAVD was as-
therefore, cannot effectively autophosphorylate on sites sessed by a liquid b-galactosidase assay (Sambrook et al., 1989).
The full-length clones of both rAPS and SH2-B were obtained bywithin or outside of the kinase domain (Cunningham et
screening a rat hippocampus cDNA phage library provided by Dr.al., 1997). The fact that members of the Lnk family bind
Paul Worley.to distinct phosphotyrosine-containing motifs in var-
ious molecules, including RTKs, the nonreceptor tyro-
Generation of DNA Constructs
sine kinase JAK2, and the IgE receptor, suggests that A series of TrkA mutants were obtained from Naoyuki Inagaki (Ina-
their highly conserved SH2 domains are promiscuous gaki et al., 1995), and cDNAs encoding the intracellular domains of
in their ability to bind to structurally distinct domains. the TrkA mutants were PCR amplified and inserted into the EcoRI
and BamHI sites of the yeast expression vector PEG202. ExpressionOn the other hand, the observation that SH2-B mutant
of the LexA±TrkA mutants was confirmed by immunoblot analysis.M5 blocked SH2-B signaling but not signaling emanat-
For coimmunoprecipitation experiments using HEK 293 cells, full-ing from wild-type TrkA in 293 cells (Figure 5) suggests
length wild-type TrkA or the TrkA mutant F8 cloned into the mamma-that the SH2-B SH2 domain does not bind to the TrkA lian expression vector p139 were used. The full coding regions of
effector binding sites that mediate SH2-B-independent rAPS and SH2-B fused to a myc epitope±tagged sequence at the
signaling in those cells. If the SH2-B SH2 domain could N terminus were subcloned into the mammalian expression vector
pRK5. Various deletions and mutations of SH2-B were constructedbind to the other TrkA effector binding sites, M5 would
in pRK5 using PCR amplification and site-directed mutagenesis.be expected to occlude binding of other TrkA effectors,
such as Shc and PLC-g, to their respective binding sites
Generation of rAPS and SH2-B Antibodieson TrkA and block all aspects of TrkA signaling. Phos-
Anti-rAPS and SH2-B sera were generated in rabbits using 6-histi-
phopeptide binding and competition experiments will dine-tagged fusion proteins containing either amino acids 66±254
be needed to identify domains of Trk that mediate the of rAPS or amino acids 176±341 of SH2-B as immunogens. The
highest-affinity and most physiologically relevant inter- corresponding cDNA fragments of rAPS and SH2-B were PCR ampli-
fied and inserted into the SacI and KpnI sites of bacterial expressionactions between phosphotyrosines in Trk receptors and
vector PTrcHisA (Invitrogen). Fusion proteins expressed in E. colirAPS and SH2-B.
were purified using Ni-NTA resin (Qiagen), and rabbits were immu-In summary, we have identified rAPS and SH2-B as
nized as described previously (Ginty et al., 1993). The IgG fractionsubstrates of Trk receptors in developing cortical and
of the antisera was purified by protein A-agarose chromatography.
sympathetic neurons. Both rAPS and SH2-B associate
with Grb2, and each has the capacity to mediate MAPK HEK 293 Cell Transfection, Immunoprecipitation,
activation and morphological differentiation of PC12 cells and Immunoblot
HEK 293 cells were cotransfected with expression vectors encodingvia a novel mechanism that is independent of Shc and
TrkA and myc±rAPS or myc±SH2-B using lipofectamine (GibcoBRL).PLC-g. Importantly, SH2-B, or a closely related mole-
Two days after transfection, cells were stimulated with NGF (100cule, is necessary for TrkA signaling in neonatal sympa-
ng/ml) for 10 min and then lysed in 1 ml of lysis buffer (1% NP-thetic neurons. Members of this new family of adaptor
40 in TBS containing 10% glycerol, 1 mM PMSF, 1 mM sodium
molecules are likely to function as general mediators of orthovanadate, 1 mg/ml aprotinin, and 1 mg/ml leupeptin [pH 7.4]).
phosphotyrosine signaling in both neuronal and nonneu- All subsequent steps were at 48C. Lysates were clarified by centri-
ronal cells and contribute to cell growth, differentiation, fugation (16,000 3 g for 20 min) and supernatants used for immu-
noprecipitations using anti-myc monoclonal antibodies (9E10). Forand survival.
immunoprecipitations from primary neurons, cortical neurons or
sympathetic neurons were stimulated with BDNF (50 ng/ml), NT-3Experimental Procedures
(100 ng/ml), or NGF (200 ng/ml) for 10 min. Extracts were prepared
as described above. Lysate supernatants were subjected to immu-Cell Lines and Primary Neuron Cultures
noprecipitation with indicated antibodies, and the immune com-HEK 293 cells were cultured in DMEM containing 10% fetal bovine
plexes were resolved by SDS-PAGE gel and blotted with anti-phos-serum (FBS) and penicillin and streptomycin (Pen/Strep). PC12nnr5
photyrosine antibodies.cells were provided by Dr. Lloyd Greene and cultured in DMEM
containing 10% FBS, 5% horse serum, and Pen/Strep. Primary corti-
MAP Kinase Assayscal neurons were cultured as described (Rosen et al., 1994). Sympa-
rAPS or SH2-B were transiently expressed with TrkA or F8 and anthetic neurons were isolated from superior cervical ganglia of neona-
tal rats (Mains and Patterson, 1973). Dissociated neurons were HA-tagged ERK1 expression vector in 293 cells. Two days after the
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